Find Galicaftor manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Abbv-2222, 1918143-53-9, Galicaftor [inn], Galicaftor [usan], Glpg2222, Glpg-2222
Molecular Formula
C28H21F4NO7
Molecular Weight
559.5  g/mol
InChI Key
QVDYQHXNAQHIKH-TZIWHRDSSA-N
FDA UNII
J0IIT8QSQS

Galicaftor
Galicaftor is under investigation in clinical trial NCT03540524 (A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GLPG2222 With or Without GLPG2737 in Patients With Cystic Fibrosis.).
1 2D Structure

Galicaftor

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(2R,4R)-4-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic acid
2.1.2 InChI
InChI=1S/C28H21F4NO7/c29-26(30)37-17-6-7-18-19(13-21(38-22(18)12-17)14-1-3-15(4-2-14)24(34)35)33-25(36)27(9-10-27)16-5-8-20-23(11-16)40-28(31,32)39-20/h1-8,11-12,19,21,26H,9-10,13H2,(H,33,36)(H,34,35)/t19-,21-/m1/s1
2.1.3 InChI Key
QVDYQHXNAQHIKH-TZIWHRDSSA-N
2.1.4 Canonical SMILES
C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4CC(OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O
2.1.5 Isomeric SMILES
C1CC1(C2=CC3=C(C=C2)OC(O3)(F)F)C(=O)N[C@@H]4C[C@@H](OC5=C4C=CC(=C5)OC(F)F)C6=CC=C(C=C6)C(=O)O
2.2 Other Identifiers
2.2.1 UNII
J0IIT8QSQS
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 4-((2r,4r)-4-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl)benzoic Acid

2. Abbv-2222

3. Glpg2222

2.3.2 Depositor-Supplied Synonyms

1. Abbv-2222

2. 1918143-53-9

3. Galicaftor [inn]

4. Galicaftor [usan]

5. Glpg2222

6. Glpg-2222

7. J0iit8qsqs

8. 4-[(2r,4r)-4-({[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl]benzoic Acid

9. Benzoic Acid, 4-((2r,4r)-4-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-7-(difluoromethoxy)-3,4-dihydro-2h-1-benzopyran-2-yl)-

10. 4-((2r,4r)-4-(((1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl)carbonyl)amino)-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl)benzoic Acid

11. Unii-j0iit8qsqs

12. Galicaftor (usan/inn)

13. Galicaftor [who-dd]

14. Chembl4101487

15. Schembl17708714

16. Ex-a6713

17. S8535

18. Who 10837

19. Abbv-2222 (glpg2222)

20. Db14894

21. Hy-111111

22. Cs-0034251

23. D11724

24. Q29208499

25. 4-[(2r,4r)-4-[[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarbonyl]amino]-7-(difluoromethoxy)-3,4-dihydro-2h-chromen-2-yl]benzoic Acid

2.4 Create Date
2016-08-06
3 Chemical and Physical Properties
Molecular Weight 559.5 g/mol
Molecular Formula C28H21F4NO7
XLogP35.7
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count11
Rotatable Bond Count7
Exact Mass559.12541466 g/mol
Monoisotopic Mass559.12541466 g/mol
Topological Polar Surface Area103 Ų
Heavy Atom Count40
Formal Charge0
Complexity957
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty